Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001563228-18-000028
Filing Date
2018-12-18
Accepted
2018-12-18 07:24:11
Documents
37
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 EASTGAT BIOTECH - 10Q -JUNE 30, 2017 - Q2 eastgatebiotechq2_2017.htm 10-Q 336124
2 EXHIBIT 31.1 exhibit31.1.htm EX-31 6426
3 EXHIBIT 31.2 exhibit31.2.htm EX-31 6533
4 EXHIBIT 32.1 exhibit32.1.htm EX-32 3324
5 EXHIBIT 32.2 exhibit32.2.htm EX-32 3531
  Complete submission text file 0001563228-18-000028.txt   1088011

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT etbi-20170630_cal.xml EX-101.CAL 21292
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT etbi-20170630_def.xml EX-101.DEF 8630
8 XBRL INSTANCE DOCUMENT etbi-20170630.xml EX-101.INS 103053
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT etbi-20170630_lab.xml EX-101.LAB 75805
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT etbi-20170630_pre.xml EX-101.PRE 61646
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT etbi-20170630.xsd EX-101.SCH 11956
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

EIN.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52886 | Film No.: 181239353
SIC: 6799 Investors, NEC